Goldman Urology Clinic has begun actively applying the latest artificial intelligence (AI) technology to the treatment of urinary stones.
The clinic recently introduced and started operating a next-generation extracorporeal shock wave lithotripsy (ESWL) system called “UROSTONE,” which incorporates AI technology. The device is equipped with Korea-patented technologies, including an AI respiratory trigger system and an AI auto-focusing function, significantly improving both treatment precision and efficiency.
Conventional shock wave lithotripsy systems often face limitations because the position of a stone can shift slightly with a patient’s breathing. When this occurs, the shock wave may miss the precise target, reducing the effectiveness of stone fragmentation. In contrast, UROSTONE uses an AI-based respiratory-synchronized targeting system that analyzes the patient’s breathing pattern in real time and tracks even subtle movements of the stone. The system automatically adjusts the shock wave targeting so that the energy continues to strike the center of the stone, improving fragmentation efficiency and shortening the procedure time.
In addition, the device features the country’s only AI-based auto-focusing function utilizing advanced image recognition technology. This system automatically analyzes and adjusts the stone’s position and focal point, maximizing treatment accuracy.
A representative from Goldman Urology Clinic explained that because the AI system simultaneously detects both the patient’s breathing and the movement of the stone, it can automatically optimize the shock wave delivery for more precise and safer stone fragmentation. The clinic expects that the technology will reduce procedure time, lower patient discomfort, and decrease the need for repeat treatments, ultimately improving overall patient satisfaction.